Call Today For a Free Consultation Call For a Free Consultation (212) 732-9000
New York Personal Injury Attorneys Click for free consultation

New York Personal Injury Attorney Blog

House Judiciary Committee Unanimously Votes in Favor of VCF Extension After Testimony from SPBMC Client and Jon Stewart, Among Others

After powerful testimony from several key figures, including SPBMC client and retired FDNY Lieutenant Michael O’Connell and former Daily Show host and 9/11 victims advocate Jon Stewart, the House Judiciary Committee unanimously voted in favor of an extension to the Victim Compensation Fund (VCF)....
Continue Reading

Vast Archive of Defective Medical Devices To Be Opened

June 11, 2019 in
Since 1999, the Food and Drug Administration (FDA) has implemented an Alternative Summary Reporting program for medical device manufacturers. Under this program, medical device makers had the authority to report incidents of patient injuries, illnesses, and even deaths due to device malfunctions only to...
Continue Reading

Johnson & Johnson Order to Pay $300 Million in Talc Damages

June 7, 2019 in
In May, a New York jury ordered Johnson & Johnson to pay $325 million in total damages to a woman who claims that the use of its talc-based products caused her to develop a rare and aggressive form of cancer, known as mesothelioma. Johnson...
Continue Reading

New York Supreme Court Appellate Division Sides with SPBMC in Personal Injury Appeal

May 24, 2019 in
The New York Supreme Court Appellate Division, Second Department in Brooklyn recently granted Sullivan, Papain, Block, McGrath & Cannavo P.C.’s appeal, filed by Counsel Stephen Glasser, in a personal injury case involving a 22-year-old man who became a quadriplegic after diving into a pool...
Continue Reading

FDA Announces a Class 1 Recall of Defective Johnson & Johnson Surgical Staplers

May 23, 2019 in
Johnson & Johnson unit Ethicon has recalled its Endo-Surgery Curved Intraluminal Stapler with Adjustable Height Staples due to a defect that may result in potential failure and misfiring. The U.S. The Food and Drug Administration (FDA) has labeled the recall as Class 1, the...
Continue Reading